Innovita Biological Technology Co., Ltd. (hammoho le lithuso tsa eona, tse tsejoang ka kakaretso e le "INNOVITA",) ke k'hamphani ea biotechnology e shebaneng le lipatlisiso, nts'etsopele, tlhahiso le thekiso ea lihlahisoa tsa POCT tsa tlhahlobo ea in vitro.E na leInnova (Beijing) , Innova (Tangshan)leInnovita (Guangzhou).
● E thehiloe ka 2006
● Litifikeiti tsa 69 tsa NMPA li fumanoe, ho kenyelletsa le litifikeiti tsa 53 tsa Sehlopha sa III
● 2020.02.22, Innovita e bile e 'ngoe ea lik'hamphani tsa pele Chaena ho fumana setifikeiti se amohetsoeng sa NMPA sa COVID-19 Antibody Test.
INNOVITA ke moetsi ea ka sehloohong oa litharollo tsa tlhahlobo bakeng sa tlhokomelo ea bophelo bo botle, e hahamallang bakeng sa tsamaiso e sebetsang ea bophelo bo botle ho ntlafatsa bophelo bo botle le boiketlo ba batho lefatšeng ka bophara.
INNOVITA e hahile li-platform tse tšeletseng tsa tekheniki tse kang tokiso ea antigen & antibody, setso sa kokoana-hloko, khauta ea colloidal, ELISA, fluorescence chromatography, immunofluorescence, 'me e etsa Lenane la R & D la National High-tech lefapheng la lipatlisiso tse kholo tsa mafu a tšoaetsanoang le merero e meng e mengata ea bophelo bo botle ba sechaba. .
INNOVITA e latela Melao ea GMP mme e na le likamore tse hloekileng tsa sehlopha sa 100,000 ho netefatsa polokeho le bohloeki ba lihlahisoa tsa rona.
Re kenya tšebetsong sistimi ea taolo ea boleng ea ISO 13485 ka tieo mme re latela litekanyetso le melaoana ea EU, FDA, joalo-joalo, ho netefatsa hore sehlahisoa se seng le se seng se fihlela litlhoko tsa bareki ba rona lefatšeng ka bophara.